Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 1991-02-04 (35 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GAILLARD (74240), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE DE GAILLARD : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE DE GAILLARD is a French company
founded 35 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GAILLARD (74240),
this company of category PME
shows in 2024 a net income positive of 300 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE DE GAILLARD (SIREN 381054287)
Indicator
2024
2023
2022
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
299 731 €
188 833 €
238 581 €
149 763 €
94 627 €
93 911 €
67 164 €
84 542 €
99 782 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE CENTRALE DE GAILLARD generates positive net income of 300 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 100 k€ -> 300 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
299 731 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 173%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
173.309%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
27.758%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE DE GAILLARD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2022
2023
2024
Debt ratio
72.316
76.116
79.199
59.6
57.415
17.151
20.896
267.607
173.309
Financial autonomy
44.114
43.8
41.866
45.462
46.444
69.662
56.133
22.448
27.758
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
173.312024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+50 pts over 3 years
In 2024, the debt ratio of PHARMACIE CENTRALE DE GAI... (173.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
27.76%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch-37 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CENTRALE DE GAI... (27.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 198.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
198.636
Liquidity indicators evolution PHARMACIE CENTRALE DE GAILLARD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2022
2023
2024
Liquidity ratio
129.382
112.495
110.427
98.992
102.515
185.729
103.366
267.632
198.636
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
198.642024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+37 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CENTRALE DE GAI... (198.64) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE CENTRALE DE GAILLARD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CENTRALE DE GAILLARD is estimated at
4 184 466 €
(range 2 913 996€ - 6 260 201€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2913k€4184k€6260k€
4 184 466 €Range: 2 913 996€ - 6 260 201€
NAF 5 année 2024
Valuation method used
Net Income Multiple
299 731 €
×
14.0x
=4 184 466 €
Range: 2 913 996€ - 6 260 201€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE DE GAILLARD with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE DE GAILLARD
What is the revenue of PHARMACIE CENTRALE DE GAILLARD ?
The revenue of PHARMACIE CENTRALE DE GAILLARD is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE CENTRALE DE GAILLARD profitable?
Yes, PHARMACIE CENTRALE DE GAILLARD generated a net profit of 300 k€ in 2024.
Where is the headquarters of PHARMACIE CENTRALE DE GAILLARD ?
The headquarters of PHARMACIE CENTRALE DE GAILLARD is located in GAILLARD (74240), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE CENTRALE DE GAILLARD ?
The tax return of PHARMACIE CENTRALE DE GAILLARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE DE GAILLARD operate?
PHARMACIE CENTRALE DE GAILLARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart